share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

SEC announcement ·  Feb 15 18:38
Summary by Moomoo AI
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], engaged in multiple acquisition transactions of the company's common stock on February 13, 2024. Burnett acquired a total of 192,050 shares through these transactions, which were classified as grants or awards. Following these acquisitions, Burnett's direct holdings in Arcutis Biotherapeutics' common stock increased to 274,082 shares. The transactions reflect a significant increase in Burnett's stake in the company, indicating a potential strengthening of the insider's commitment to the firm's future.
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], engaged in multiple acquisition transactions of the company's common stock on February 13, 2024. Burnett acquired a total of 192,050 shares through these transactions, which were classified as grants or awards. Following these acquisitions, Burnett's direct holdings in Arcutis Biotherapeutics' common stock increased to 274,082 shares. The transactions reflect a significant increase in Burnett's stake in the company, indicating a potential strengthening of the insider's commitment to the firm's future.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more